Table 1 The baseline characteristics of included patients.
Group I (n = 22) | Group II (n = 30) | Group III (n = 48) | P | |
|---|---|---|---|---|
Age, years | 65.4 (3.29) | 68.81 (3.17) | 66.71 (1.83) | 0.699 |
Sex (male) | 14 | 16 | 26 | 0.263 |
Time to PTGBD, days | 3.45 (0.28) | 3.18 (0.28) | 2.59 (1.83) | 0.199 |
Time intervals between PTGBD and LC, days | 5.28 (0.27) | 22.93 (1.33) | 52.19 (5.09) | < 0.001 |
BMI, kg/m2 | 23.28 (0.81) | 23.5 (0.56) | 23.7 (0.50) | 0.89 |
Temperature, ° | 37.38 (0.18) | 37.5 (0.14) | 37.42 (0.13) | 0.876 |
WBC, 109/L | 12.84 (0.99) | 14.8 (1.46) | 13.19 (0.14) | 0.507 |
PLT, 109/L | 147.17 (11.96) | 156.77 (8.90) | 161.73 (10.62) | 0.672 |
CRP, mg/L | 99.7 (11.90) | 102.75 (13.53) | 106.14 (10.62) | 0.924 |
AST, U/L | 150.83 (19.32) | 186.71 (63.95) | 100.17 (27.60) | 0.284 |
ALT, U/L | 120.5 (23.87) | 267.71 (93.172) | 158.91 (14.24) | 0.151 |
ALP, U/L | 120.67 (11.91) | 113.28 (9.51) | 126.73 (14.24) | 0.817 |
Creatine, μmol/L | 76.5 (4.82) | 72.23 (6.17) | 77.09 (17.07) | 0.829 |
Combines comorbid | 10 (45.45) | 17 (56.67) | 24 (50.00) | 0.713 |
Cardiovascular disease | 6 (27.27) | 9 (30.00) | 10 (20.83) | |
Diabetes mellitus | 1 (4.55) | 3 (10.00) | 4 (8.33) | |
COPD | 1 (4.55) | 2 (6.67) | 3 (6.25) | |
Chronic renal failure | 1 (4.55) | 0 (0) | 2 (4.17) | |
MT | 0 (0) | 2 (6.67) | 2 (4.17) | |
Others | 1 (4.55) | 1 (3.33) | 3 (6.25) | |
ASA (I/II/III/IV/V) | 3/9/7/3/0 | 5/9/10/6/0 | 6/14/16/12/0 | 0.929 |
CCI | 3.32 (0.12) | 3.18 (0.11) | 3.28 (0.07) | 0.617 |
Severity of AC | ||||
Grade I | 4 (18.18) | 8 (26.67) | 8 (16.67) | 0.546 |
Grade II | 17 (77.27) | 22 (73.33) | 38 (79.17) | 0.837 |
Grade III | 1 (4.55) | 0 (0) | 2 (4.17) | 0.514 |
Previous abdominal surgery | 3 (13.64) | 2 (6.67) | 5 (10.42) | 0.701 |
